Citations

Citations

We’ve gathered published citations for the past many years so that researchers can easily review at their convenience from among the thousands of published articles, how they might use our products in detail or apply these ideas to their own novel thinking for new research.

Search through, read and share our information rich citations below!

Contact us with any questions.

4784 total record number 156 records this year

To narrow your search, use one or more of the following search menus below.

To search by keyword, you may search by the cell/animal/assay/protein/research or publication
Page 125 out of 479
4784 citations found

Inactivation of Rho GTPases by Burkholderia cenocepacia Induces a WASH-Mediated Actin Polymerization that Delays Phagosome Maturation

Walpole, GFW;Plumb, JD;Chung, D;Tang, B;Boulay, B;Osborne, DG;Piotrowski, JT;Catz, SD;Billadeau, DD;Grinstein, S;Jaumouill, V;

Product: Toxin B from Clostridium difficile

Product: Anti-Cholera Toxin B Subunit (Goat)

  • … Free-floating sections were washed in 0.01 M PBS, followed by incubation in hydrogen peroxide for 20 min and incubated for 24 h at room temperature (RT) with a goat anti-CT-B antibody (1:10,000 List Biological Laboratories, CA, USA) …

    Product #703 – Anti-Cholera Toxin B Subunit (Goat)

Nasal vaccination of β7 integrin-deficient mice retains elevated IgA immunity

Ma?lanka, T;Clapp, B;Hoffman, C;Robison, A;Gregorczyk, I;Pascual, DW;

Product: Cholera Toxin (AZIDE-FREE) from Vibrio cholerae

Safety, immunogenicity, and clinical efficacy of durvalumab in combination with folate receptor alpha vaccine TPIV200 in patients with advanced ovarian cancer: a phase II trial

Zamarin, D;Walderich, S;Holland, A;Zhou, Q;Iasonos, AE;Torrisi, JM;Merghoub, T;Chesebrough, LF;Mcdonnell, AS;Gallagher, JM;Li, Y;Hollmann, TJ;Grisham, RN;Erskine, CL;Block, MS;Knutson, KL;O'Cearbhaill, RE;Aghajanian, C;Konner, JA;

Product: Tetanus Toxoid from Clostridium tetani

  • IFNγ ELISPOT assay

    Peripheral blood mononuclear cells (PBMCs) were collected using mononuclear cell preparation tubes (CPT) prior to treatment initiation and at 3 and 6 weeks and were cryopreserved in liquid nitrogen at 5×106 cells per vial in cryopreservation media containing 10% dimethyl sulfoxide (DMSO). The procedure for the FRα ELISPOT assay has been described previously.22 Briefly, 2.5×105 PBMCs/well were plated in triplicate into 96-well round bottom plates in 200 µL of RPMI1640 containing L-glutamine, penicillin, streptomycin, and 10% serum (T cell medium), along with cyclin D1 (control) peptide (MELLLVNKLKWNLAA), FR30, FR56, FR76, FR113, FR238, FRα protein (Sino Biological), tetanus toxoid (List Biological Laboratories), …

    Product #191 – Tetanus Toxoid from Clostridium tetani

Vaccine-mediated protection against Campylobacter-associated enteric disease

Quintel, B;Prongay, K;Lewis, A;Rau, H;Hendrickson, S;Rhoades, N;Messaoudi, I;Gao, L;Slifka, M;Amanna, I;

Product: LPS from Escherichia coli O111:B4

  • Safety assessment in mice and RMs

    For preliminary safety studies, 8-week-old female BALB/c mice were obtained from the Jackson laboratory (Bar Harbor, ME) and immunized by the intraperitoneal route with a 40-μg dose of H2O2-CampyC. In a separate control study, mice were treated with 10 μg of E. coli LPS (O111:B4, List Biological Laboratories, Campbell, CA). Animal weights were followed for up to 1 week after immunization. The second phase of our safety assessment was conducted in RM. Two adult females received an IM vaccination with the H2O2-CampyC vaccine, and two adult females received a mock, alum-only IM vaccination. Health metrics, including weight, attitude, appetite, urine, stool, temperature, and vaccine site, were monitored daily for 14 days.

    Product #201 – LPS from Escherichia coli O111:B4

Product: Botulinum Neurotoxin Type A from Clostridium botulinum

  • BoNT administration

    Research-grade, purified, native BoNT serotype A1 (BoNT-A; 150 kDa) was purchased from List Biological Laboratories (Campbell, CA, USA). It was reconstituted in 1 mg/ml phosphate buffer saline/bovine serum albumin (0.1%) to obtain a stock solution, which was aliquoted and kept frozen at −80 °C. Dilutions of aliquots were performed with 0.2% gelatin phosphate buffer (GPB) to obtain the final concentrations (see below). …

Ocular Surface Ectoderm Instigated by WNT inhibition and BMP4

Kobayashi, Y;Hayashi, R;Shibata, S;Quantock, A;Nishida, K;

Product: Cholera Toxin (AZIDE-FREE) from Vibrio cholerae

  • Flow cytometry and cell sorting

    p63-EGFP knock-in hiPSCs were differentiated for 10 days or 6 weeks, dissociated with Accutase (Thermo Fisher Scientific) for 60–90 min at 37 °C, harvested through a 40 μm cell strainer (BD Biosciences, San Diego, CA), and collected into keratinocyte culture medium (KCM; a 3:1 mix of DMEM without glutamine and Nutrient Mixture F-12 Ham; Thermo Fisher Scientific) supplemented with 5% fetal bovine serum (Japan Bio Serum, Hiroshima, Japan), 0.4 μg/mL hydrocortisone succinate (Wako), 2 nM 3,3′,5-triiodo-l-thyronine sodium salt (MP Biomedicals, Santa Ana, CA), 1 nM cholera toxin (List Biological Laboratory, Campbell, CA), 2.25 μg/mL bovine transferrin HOLO form (Thermo Fisher Scientific), 2 mM L-glutamine, 0.5% insulin transferrin selenium (Thermo Fisher Scientific), and 1% penicillin–streptomycin. Cells were washed in phosphate-buffered saline. The 1383D2 cell line was used as an EGFP (enhanced green fluorescent protein) negative control. Cells were sorted on a SH800 Cell Sorter (Sony Biotechnology Inc., Tokyo, Japan) and the data were analyzed using SH800 software.

    Product #100B – Cholera Toxin (AZIDE-FREE) from Vibrio cholerae

A stable protocol for the fabrication of transplantable human oral mucosal epithelial cell sheets for clinical application

Kasai, Y;Takagi, R;Kobayashi, S;Owaki, T;Yamaguchi, N;Fukuda, H;Sakai, Y;Sumita, Y;Kanai, N;Isomoto, H;Kanetaka, K;Ohki, T;Asahina, I;Nagai, K;Nakao, K;Takeda, N;Okano, T;Eguchi, S;Yamato, M;

Product: Cholera Toxin (AZIDE-FREE) from Vibrio cholerae

  • Preparations

    … The preparation of the keratinocyte culture medium (KCM) is as follows; Dulbecco’s modified Eagle’s medium (DMEM; Sigma aldrich, MO, USA) and F-12 medium (Sigma aldrich) were mixed at a 3:1 ratio. The medium was supplemented with 3.3 mM l-glutamine solution (Sigma Aldrich), 84 μM gentamicin (Merck Sharp and Dohme, NJ, USA), 0.3 μM amphotericin B (Bristol-Myers Squibb, NY, USA), 0.25 μM hydrocortisone (Kowa, Nagoya, Japan), 140 mU/mL insulin (Lilly, IN, USA), 2.0 nM 3,3′,5-Triiodo-l-thyronine (MP Biomedicals, CA, USA), 1.0 nM cholera toxin (List Biological Laboratories, CA, USA), …

    Product #100B – Cholera Toxin (AZIDE-FREE) from Vibrio cholerae

Macrophage Inflammatory State Influences Susceptibility to Lysosomal Damage

Wong, A;Marthi, M;Owusu, I;Wobus, C;Swanson, J;

Product: LPS from Salmonella typhimurium

  • Cell culture and stimulation

    CA-Mφ were generated by priming BMM with 150 U/ml IFN-γ (R&D Systems, Minneapolis, MN) for 6 h, and then stimulating cells overnight with 150 U/ml IFN-γ and 100 ng/ml LPS (from Salmonella typhimurium; no. 225; List Biological Laboratories, Campbell, CA). …

    Product #225 – LPS from Salmonella typhimurium

Product: Cholera Toxin (AZIDE-FREE) from Vibrio cholerae

  • Cell lines

    … MCF-10A cell lines were maintained in the full growth medium, which consisted of DMEM/F12 (1:1) (Cat#11330-032, Gibco) supplemented with 5% horse serum (Cat#16050-122,
    Invitrogen), 10 mg/ml insulin (Cat#12878-44, Nacalai Tesque), 0.5 mg/ml hydrocortisone (Cat#1H-0888, Invitrogen), 100 ng/ml cholera toxin (Cat#101B, List Biological Laboratories), …

    Product #100B – Cholera Toxin (AZIDE-FREE) from Vibrio cholerae